Nephrocare Health IPO
Nephrocare Health IPO
Overview
Nephrocare Health IPO is a book build issue . The issue comprises of fresh issue of ₹353.41 crores and offer for sale of 1.13 crore shares. Nephrocare Health IPO opens for subscription on Dec 10, 2025 and closes on Dec 12, 2025. The allotment for the Nephrocare Health IPO is expected to be finalized on Dec 15, 2025. Nephrocare Health IPO will list on BSE, NSE with a tentative listing date fixed as Dec 17, 2025. Nephrocare Health IPO price band is set at [.] to [.] per share . ICICI Securities Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Total Shares
0
Issue Size
-
Price Band
₹0 – ₹0
Lot Size
0 shares
Min. Investment
₹0
Max. Investment
₹0
Open Date
10 Dec, 2025
Close Date
12 Dec, 2025
Allotment
15 Dec, 2025
Listing
17 Dec, 2025
Max. Investment
₹0
Announced
10 Dec, 2025
Opening Date
10 Dec, 2025
Closing Date
12 Dec, 2025
Basis of Allotment
15 Dec, 2025
Initiation of Refunds
16 Dec, 2025
Credit of Shares
16 Dec, 2025
Listing Date
17 Dec, 2025
Live GMP
Est. Listing: ₹18
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Nephrocare Health IPO
Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets. The company offers services including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy.
As of Sep 30, 2025, Nephrocare operated 519 clinics with 51 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In
Nephrocare Health IPO Share Price
Issue Breakdown
Shareholding
Nephrocare Health IPO Promoters Holding
Vikram Vuppala, Bessemer Venture Partners Trust, Edoras Investment Holdings Pte. Ltd., Healthcare Parent Limited, Investcorp Private Equity Fund II and Investcorp Growth Opportunity Fund are the company promoters.
Nephrocare Health IPO Financial Health
Nephrocare Health Services Ltd.'s revenue increased by 34% and profit after tax (PAT) rose by 91% between the financial year ending with March 31, 2025 and March 31, 2024.
Nephrocare Health IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| - | - | - | - |
(All values in CR)
Nephrocare Health IPO Valuations
| Metric | Value |
|---|---|
| ROE | 13.45 |
| ROCE | 18.67 |
| RoNW | 13.19 |
| PAT Margin | 8.88 |
| EBITDA Margin | 22.05 |
(All values in CR)
Nephrocare Health IPO Strength & Risk
Nephrocare Health IPO Strength:
Operates in the specialised kidney care and dialysis segment with strong long-term demand.
Recognised as a leading organised player in the renal care industry.
Offers a wide range of services including in-centre dialysis, home dialysis, mobile dialysis, diagnostics, and wellness support.
Benefits from recurring revenue due to the chronic nature of kidney-related treatments.
Well-established brand presence enhances trust among patients and healthcare partners.
Expansion plans backed by IPO funding support wider geographic reach.
Backed by institutional investors, improving financial stability and governance standards.
Nephrocare Health IPO Risk:
Highly dependent on healthcare regulations, licensing requirements, and quality compliance.
High capital investment required for setting up dialysis centres and medical facilities.
Faces competition from hospitals, private dialysis chains, and standalone clinics.
Operational expansion carries risk of underutilised centres or higher operating costs.
Patient volumes may be influenced by policy changes, reimbursement systems, or economic conditions.
Service quality and patient experience must be consistently maintained during rapid scaling.
Offer-for-sale component may raise sentiment concerns regarding existing investor exits.
Nephrocare Health IPO Subscriptions Status
Nephrocare Health IPO subscribed 0.37 times. The public issue subscribed 0.47 times in the retail category, 0.29 times in QIB (Ex Anchor), and 0.23 times in the NII category by December 11, 2025 5:59:37 PM (Day 2).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 56,57,919 | 56,57,919 | 260.264 |
| QIB (Ex Anchor) | 0.29 | 37,68,224 | 10,91,840 | 50.225 |
| Non-Institutional Buyers | 0.23 | 28,27,843 | 6,42,400 | 29.55 |
| bNII (bids above ₹10L) | 0.16 | 18,85,229 | 3,00,448 | 13.821 |
| sNII (bids below ₹10L) | 0.36 | 9,42,614 | 3,41,952 | 15.73 |
| Retail | 0.47 | 65,98,301 | 30,90,624 | 142.169 |
| Employees | 1.25 | 83,532 | 1,04,576 | 4.81 |
| Total | 0.37 | 1,32,77,900 | 49,29,440 | 226.754 |
Nephrocare Health IPO GMP
Nephrocare Health IPO last GMP is ₹17.5, last updated Dec 11th 2025 05:29 PM. With the price band of 460.00, Nephrocare Health IPO's estimated listing price is ₹477.5 (cap price + today's GMP).The expected percentage gain/loss per share is 3.80%. >> Nephrocare Health IPO Retail Subject to Sauda: ₹400 >> Nephrocare Health IPO Small HNI Subject to Sauda: ₹5600 The lowest GMP is ₹0.00, while the highest GMP is ₹20.00.
Last updated 11 Dec, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 11 Dec, 2025 | 460 | ₹17.5▼ | 400/5600 | ₹477.5 (3.80%) | 560 | 11 Dec, 2025 |
| 10 Dec, 2025 | 460 | ₹20▲ | 500/7000 | ₹480 (4.35%) | 640 | 10 Dec, 2025 |
| 09 Dec, 2025 | 460 | ₹0 | - | ₹460 (0.00%) | - | 09 Dec, 2025 |
| 08 Dec, 2025 | 460 | ₹0 | - | ₹460 (0.00%) | - | 08 Dec, 2025 |
| 07 Dec, 2025 | 460 | ₹0 | - | ₹460 (0.00%) | - | 07 Dec, 2025 |
| 06 Dec, 2025 | 460 | ₹0 | - | ₹460 (0.00%) | - | 06 Dec, 2025 |
| 04 Dec, 2025 | 460 | ₹0 | - | ₹460 (0.00%) | - | 04 Dec, 2025 |
| 03 Dec, 2025 | 0 | ₹0 | - | ₹ (%) | - | 03 Dec, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Nephrocare Health IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Nephrocare Health IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.